Market Overview:
The global natural killer cell therapy market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer and other gastrointestinal diseases, rising demand for targeted therapies, and growing focus on personalized medicine. The NK cell therapies segment is expected to account for the largest share of the global natural killer cell therapy market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period. The NK cell directed antibodies segment is projected to grow at a higher CAGR than the NK cell therapies segment during the forecast period. Oncology is estimated to be the largest application area for natural killer cells therapies in 2018. This application area accounted for a share of XX% of this market in 2017 and it is projected to reach a value of USD XXX million by 2030.
Product Definition:
Natural Killer Cell Therapy is the use of natural killer cells to treat cancer or other diseases. Natural killer cells are a type of white blood cell that helps the body fight infection and disease. They can also kill cancer cells.
NK Cell Therapies:
Natural killer (NK) cells are a type of white blood cell that constitutes about 1% to 3% of the total blood volume. They are responsible for identifying and killing infected or diseased cells without distinguishable between healthy and unhealthy tissues.
NK Cell Directed Antibodies:
Natural killer (NK) cell directed antibodies are a new type of therapy that is gaining traction in the oncology market. NK cell directed antibodies have been observed to be effective in various types of cancer such as lymphomas, leukemias, and myelomas. The mechanism by which these cells act against cancer cells is through the release of cytokines and chemotherapeutic agents by these cells.
Application Insights:
The application segment is segregated into cancer, gastrointestinal diseases, and others. The cancer segment dominated the global market in 2017 owing to the rising prevalence of various cancers such as B-cell lymphoma, Non-hodgkin¢â‚¬â„¢s lymphoma and multiple myeloma. Moreover, this disease is also associated with a high mortality rate which boosts the demand for natural killer cell therapy during treatment.
The use of natural killer cells for tumor eradication has been proved to be effective in several clinical trials conducted over the past few years. This factor is responsible for driving this segment growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to presence of key players, increased research activities, and availability of effective treatment for various cancers and infectious diseases. Moreover, increasing incidence of cancer is also one of the major factors responsible for its largest share. According to the American Cancer Society (ACS), Inc., around 2 million new cases will be diagnosed in U.S during 2018-19 and more than 1 million people will die from it that year.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the key growth drivers for the natural killer cell therapy market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This growing prevalence of cancer is expected to drive demand for natural killer cell therapies over the forecast period.
- Rising awareness about benefits of natural killer cells: There is a rising awareness among people about the benefits of using natural killer cells for treating various diseases such as cancer and autoimmune disorders. This is expected to boost demand for these therapies over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Natural Killer Cell Therapy Market Research Report
By Type
NK Cell Therapies, NK Cell Directed Antibodies
By Application
Cancer, Gastrointestinal Diseases, Others
By Companies
Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, Nkarta Therapeutics, NantKwest
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Natural Killer Cell Therapy Market Report Segments:
The global Natural Killer Cell Therapy market is segmented on the basis of:
Types
NK Cell Therapies, NK Cell Directed Antibodies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Gastrointestinal Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Glycostem Therapeutics
- Fate Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- Nkarta Therapeutics
- NantKwest
Highlights of The Natural Killer Cell Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- NK Cell Therapies
- NK Cell Directed Antibodies
- By Application:
- Cancer
- Gastrointestinal Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Natural Killer Cell Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Natural Killer Cell Therapy (NKT) is a type of cancer treatment that uses the body's natural killer cells to fight cancer. NKT works by helping the body's immune system to identify and attack cancer cells.
Some of the major players in the natural killer cell therapy market are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, Nkarta Therapeutics, NantKwest.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Natural Killer Cell Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Natural Killer Cell Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Natural Killer Cell Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Natural Killer Cell Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Natural Killer Cell Therapy Market Size & Forecast, 2020-2028
4.5.1 Natural Killer Cell Therapy Market Size and Y-o-Y Growth
4.5.2 Natural Killer Cell Therapy Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 NK Cell Therapies
5.2.2 NK Cell Directed Antibodies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Gastrointestinal Diseases
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Natural Killer Cell Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Natural Killer Cell Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 NK Cell Therapies
9.6.2 NK Cell Directed Antibodies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Gastrointestinal Diseases
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 NK Cell Therapies
10.6.2 NK Cell Directed Antibodies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Gastrointestinal Diseases
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 NK Cell Therapies
11.6.2 NK Cell Directed Antibodies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Gastrointestinal Diseases
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 NK Cell Therapies
12.6.2 NK Cell Directed Antibodies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Gastrointestinal Diseases
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 NK Cell Therapies
13.6.2 NK Cell Directed Antibodies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Gastrointestinal Diseases
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Natural Killer Cell Therapy Market: Competitive Dashboard
14.2 Global Natural Killer Cell Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Nektar Therapeutics
14.3.2 Innate Pharma SA
14.3.3 Affimed
14.3.4 Chipscreen Biosciences
14.3.5 Glycostem Therapeutics
14.3.6 Fate Therapeutics
14.3.7 Dragonfly Therapeutics
14.3.8 Kiadis Pharma
14.3.9 Nkarta Therapeutics
14.3.10 NantKwest
